Jason C Gallagher Selected Research

Jason C Gallagher Research Topics

Disease

16	Infections 02/2022 - 02/2003
5	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2018
3	Intraabdominal Infections 01/2020 - 01/2018
3	Hypersensitivity (Allergy) 11/2019 - 02/2009
3	Mycoses (Diseases, Fungus) 04/2011 - 02/2003
2	COVID-19 01/2022 - 01/2022
2	Pseudomonas Infections 03/2021 - 11/2018
2	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2018
2	Bacterial Pneumonia 01/2020 - 01/2019
2	Drug-Related Side Effects and Adverse Reactions 11/2019 - 07/2009
2	Nausea 11/2019 - 11/2011
2	Pneumonia (Pneumonitis) 01/2019 - 01/2018
2	Sepsis (Septicemia) 01/2015 - 10/2014
2	Bacteremia 01/2015 - 07/2009
2	Invasive Fungal Infections 04/2011 - 04/2004
2	Fever (Fevers) 01/2010 - 07/2009
1	Urinary Tract Infections (Urinary Tract Infection) 01/2020
1	Vomiting 11/2019
1	Injection Site Reaction 11/2019
1	Diarrhea 11/2019
1	Community-Acquired Infections 01/2018
1	Cystitis 01/2018
1	Ventilator-Associated Pneumonia 01/2018
1	Soft Tissue Infections 01/2018
1	Pyelonephritis 01/2018
1	Clostridium Infections 11/2015
1	Meningitis 03/2015
1	Drug Hypersensitivity (Drug Allergy) 12/2014
1	Critical Illness (Critically Ill) 08/2013
1	Osteomyelitis 06/2012
1	Foreign Bodies (Foreign Body) 06/2012
1	Pulmonary Tuberculosis 11/2011
1	Febrile Neutropenia 04/2011
1	Neutropenia 04/2011
1	Drug Fever 01/2010
1	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 01/2009
1	Acinetobacter Infections 09/2008

Drug/Important Bio-Agent (IBA)

6	Carbapenems (Carbapenem Antibiotics)IBA 02/2022 - 02/2009
5	Pharmaceutical PreparationsIBA 01/2017 - 01/2010
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 09/2008
3	beta-LactamsIBA 01/2020 - 02/2009
3	Vancomycin FDA LinkGeneric 11/2015 - 07/2009
3	Amphotericin B (Amphotericin)FDA LinkGeneric 04/2011 - 02/2003
2	tazobactam drug combination ceftolozaneIBA 03/2021 - 11/2018
2	LactamsIBA 11/2019 - 01/2015
2	Ertapenem (Invanz)FDA Link 11/2019 - 01/2016
2	ceftazidime drug combination avibactamIBA 01/2017 - 01/2017
2	Tigecycline (Tygacil)FDA Link 01/2017 - 09/2008
2	Penicillins (Penicillin)FDA Link 12/2014 - 02/2009
2	Immunoglobulin E (IgE)IBA 12/2014 - 02/2009
2	Monobactams (Monobactam Antibiotics)IBA 12/2014 - 02/2009
2	beta Lactam AntibioticsIBA 12/2014 - 02/2009
2	Daptomycin FDA Link 06/2012 - 07/2009
2	Moxifloxacin (Avelox)FDA Link 11/2011 - 01/2009
2	Antifungal AgentsIBA 04/2011 - 03/2010
2	AzolesIBA 04/2011 - 03/2010
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2021
1	beta-Lactamase InhibitorsIBA 01/2020
1	eravacyclineIBA 11/2019
1	Meropenem (Merrem)FDA LinkGeneric 11/2019
1	omadacyclineIBA 01/2019
1	carbapenemaseIBA 05/2018
1	AminoglycosidesIBA 01/2017
1	Fosfomycin FDA Link 01/2017
1	Polymyxins (Polymyxin)IBA 01/2017
1	FidaxomicinIBA 11/2015
1	Ceftaroline FDA Link 03/2015
1	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2014
1	Third Generation CephalosporinsIBA 10/2014
1	Colistin (Coly-Mycin)FDA Link 08/2013
1	EchinocandinsIBA 04/2011
1	Anti-Infective Agents (Microbicides)IBA 01/2010
1	Creatine Kinase (Creatine Phosphokinase)IBA 07/2009
1	Aztreonam FDA LinkGeneric 02/2009
1	Ceftazidime (Fortum)FDA LinkGeneric 02/2009

Therapy/Procedure

12	Therapeutics 01/2022 - 07/2009
5	Drug Therapy (Chemotherapy) 01/2018 - 02/2003
1	Mechanical Ventilators (Ventilator) 01/2020
1	Lasers (Laser) 01/2019
1	Duration of Therapy 01/2018
1	Ventriculoperitoneal Shunt 03/2015
1	Lung Transplantation 03/2010
1	Intravenous Administration 02/2003
1	Secondary Prevention 02/2003